VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Canadian Small/Micro Cap Top picks for 2021

<< Previous

Bullboard Posts

Next >>

Comment by SunsetGrillon Jan 08, 2021 12:32pm

117 Views

Post# 32254593

RE:RE:RE:RE:RE:Canadian Small/Micro Cap Top picks for 2021

NO - not a big difference at all. AND they dont have enough money for 12-18 mos.

Such a big difference - how come NO sales??

Banderas1209 wrote: The VMS3.0 is not out for 10 years!

they exist 10 years and you know the first 2 where far from great and user friendly

VMS 3.0 is really operational since 2020

big difference

Either way if nothing happens the next 12-18 months I will give the credits but I still believe in it